Cancer Network
..... These results raise two questions, Kang wrote: whether the CHORUS
findings apply to expert surgeons, and which patients would benefit most
from this treatment strategy.
“Concerns are also increasing that
neoadjuvant chemotherapy could be used as an excuse for neglecting
maximum surgical efforts or improvement of competent surgical skills,”
Kang wrote. “Despite these questions and concerns, Kehoe and
colleagues are to be congratulated on their research showing that
neoadjuvant chemotherapy lowers treatment-related morbidity without
sacrificing treatment efficacy. However, efforts should now be directed
towards identifying and resolving the remaining uncertainties.”
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.